Fetal Alcohol Research (FAR)
Fetal Alcohol Research (FAR) is the successor of the Fetal Alcohol Syndrome International Journal. In 2007, Fetal Alcohol Research was created as a new section within the Journal of Population Therapeutics and Clinical Pharmacology.
Fetal Alcohol Research disseminates evidence-based, peer reviewed research from all over the world on all aspects of prenatal alcohol exposure, in the domains of prevention, etiology, diagnosis, and management of affected individuals. The journal also publishes findings on alcohol consumption along with drugs of abuse, poverty, seclusion, and how these gestational exposures have an impact on developing fetuses, children, adults, their families, and society as a whole.
Fetal Alcohol Research is issued 3 times per year and available free for download on PubMed. The Editorial team welcomes original research, reviews, commentaries, Letters to the Editor, and case reports from leading researchers and clinicians in the field.
Please refer to the general Submission Guidelines for the preparation of the manuscript for submission in the "About Us" section for Journal of Population Therapeutics and Clinical Pharmacology.
Article Type Submission Guidelines for Fetal Alcohol Research manuscripts
Original Research - maximum 2500 words (not including structured abstract, online material, tables, figures, references, legends) with a structured Abstract (150 words) Tables: 5 maximum Figures: 5 maximum
Review Article - maximum of 4000 words (not including structured abstract, online material, tables, figures, references, legends) with a structured Abstract (150 words) Tables: 4 Figures: 4 References: 50
Commentary / Short Communication / Case Report - maximum of 1000 words (not including online material, tables, figures, references, legends) Tables: 3 Figures: 3
Letter to the Editor - maximum of 400 words and 5 References (one reference to link to the article), Corresponding Author email, full names, degrees and affiliations
Deputy Editor- in- Chief : Irena Nulman, MD
Irena Nulman, MD, MSc, FRCPC, Neurology, PhD
Professor of Pediatrics and Pharmacology, University of Toronto
Staff, Division of Clinical Pharmacology and Toxicology
The Hospital for Sick Children, Toronto, Canada
Director, Fetal Alcohol Syndrome Clinic
Associate Director Motherisk Program
University of Toronto Fellowship Program Director, Clinical Pharmacology
Senior Associate Scientist Child Health Evaluative Sciences (CHES)
Associate Editor- Tom Leibson, MD